EKF Diagnostics Holdings plc
EKDHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $25 | $25 | $25 | $26 |
| % Growth | 1% | -0.9% | -2% | – |
| Cost of Goods Sold | $13 | $13 | $13 | $13 |
| Gross Profit | $13 | $12 | $12 | $12 |
| % Margin | 50.2% | 49.4% | 47.8% | 48.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $9 | $0 | $0 | $0 |
| SG&A Expenses | $9 | $9 | $9 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $9 | $9 | $9 |
| Operating Income | $4 | $3 | $3 | $4 |
| % Margin | 14.2% | 13.7% | 11.5% | 14.3% |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$2 |
| Pre-Tax Income | $4 | $3 | $3 | $2 |
| Tax Expense | $2 | -$1 | $1 | -$1 |
| Net Income | $2 | $4 | $2 | $3 |
| % Margin | 7.7% | 16.7% | 8.2% | 10.5% |
| EPS | 0.004 | 0.009 | 0.005 | 0.006 |
| % Growth | -53.3% | 100% | -23.3% | – |
| EPS Diluted | 0.004 | 0.009 | 0.005 | 0.006 |
| Weighted Avg Shares Out | 452 | 454 | 454 | 454 |
| Weighted Avg Shares Out Dil | 452 | 454 | 454 | 454 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | $5 | $6 | $6 | $4 |
| % Margin | 21% | 22.4% | 22% | 17.1% |